RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis AI Analysis of AXSM
Powered by GPT-4o
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Friday for Axsome Therapeutics
(Updated on Sep 13, 2024)

Buy or Hold candidate since Jun 24, 2024 Gain 19.32% PDF

The Axsome Therapeutics stock price gained 2.09% on the last trading day (Friday, 13th Sep 2024), rising from $91.75 to $93.67. During the last trading day the stock fluctuated 3.30% from a day low at $91.72 to a day high of $94.75. The price has been going up and down for this period, and there has been a 5.12% gain for the last 2 weeks. Volume fell on the last day by -33 thousand shares and in total, 236 thousand shares were bought and sold for approximately $22.08 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 18.80% during the next 3 months and, with a 90% probability hold a price between $105.76 and $115.59 at the end of this 3-month period.

Have specific questions? Chat with our AI Analyst now!

AXSM Signals & Forecast

The Axsome Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $92.87 and $88.03. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, September 04, 2024, and so far it has fallen -1.98%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Axsome Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $80.50 and $78.50. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Axsome Therapeutics finds support just below today's level at $80.50. If this is broken, then the next support from accumulated volume will be at $78.50 and $76.00.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.03 between high and low, or 3.30%. For the last week, the stock has had daily average volatility of 3.12%.

Our recommended stop-loss: $90.54 (-3.34%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 24 days ago.)

Trading Expectations (AXSM) For The Upcoming Trading Day Of Monday 16th

For the upcoming trading day on Monday, 16th we expect Axsome Therapeutics to open at $93.38, and during the day (based on 14 day Average True Range), to move between $90.64 and $96.70, which gives a possible trading interval of +/-$3.03 (+/-3.23%) up or down from last closing price. If Axsome Therapeutics takes out the full calculated possible swing range there will be an estimated 6.47% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $93.69 (0.02%) than the support at $80.50 (14.06%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Axsome Therapeutics stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Axsome Therapeutics stock to perform well in the short-term.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Current score: 2.899 Buy Candidate Unchanged

Predicted Opening Price for Axsome Therapeutics of Monday, September 16, 2024

Fair opening price September 16, 2024 Current price
$93.38 ( 0.310%) $93.67

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AXSM

Fibonacci Support & Resistance Levels

Level Price
R3 96.41 2.93%
R2 95.25 1.69%
R1 94.54 0.93%
Price 93.67
S1 92.22 -1.55%
S2 91.51 -2.31%
S3 90.35 -3.54%

Accumulated Volume Support & Resistance Levels

Level Price
R3 95.56 2.02%
R2 94.09 0.448%
R1 93.69 0.0214%
Price 93.67
S1 80.50 -14.06%
S2 78.50 -16.20%
S3 76.00 -18.86%

FAQ

What is the symbol for Axsome Therapeutics Stock and on which exchange is it traded?
The symbol for Axsome Therapeutics is AXSM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Axsome Therapeutics Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Axsome Therapeutics stock to perform well in the short-term.

How to buy Axsome Therapeutics Stock?
Axsome Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Axsome Therapeutics Stock.

What's the current price of Axsome Therapeutics Stock?
As of the end of day on the Sep 13, 2024, the price of an Axsome Therapeutics (AXSM) share was $93.67.

What is the 52-week high and low for Axsome Therapeutics Stock?
The 52-week high for Axsome Therapeutics Stock is $98.40 and the 52-week low is $55.03.

What is the market capitalization of Axsome Therapeutics Stock?
As of the Sep 13, 2024, the market capitalization of Axsome Therapeutics is 4.496B.

When is the next earnings date for Axsome Therapeutics?
The upcoming earnings date for Axsome Therapeutics is Nov 04, 2024.
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT